# US 6,730,500 B1 · Methods for generating a continuous nucleotide sequence from noncontiguous nucleotide sequences

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,500 B1
- Document ID: US6730500B1
- Status: Granted
- Kind: B1
- Application number: 09/938,077
- Filed: 2001-08-23
- Granted: 2004-05-04
- Earliest claimed: 2000-08-30
- Assignees: ZymoGenetics, Inc.
- Inventors: Si Lok
- Web page: https://patentgrep.com/patent/US6730500B1

## CPC

- C12N 15/66: General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The increased use of nucleotide sequence data mining techniques has amplified the demand for efficient methods of producing recombinant proteins in host cells. New genes identified from genomic sequences may lack an identified source for obtaining an mRNA template to produce cDNA. A strategy is provided for generating nucleic acid molecules comprising a continuous amino acid-encoding sequence using a genomic template that contains non-continuous amino acid-encoding sequences.

## Claims

### Claim 1

A method for producing a nucleic acid molecule that comprises a continuous nucleotide sequence capable of being transcribed and translated to produce a protein of interest, the nucleic acid molecule derived from noncontiguous nucleotide sequences, comprising:
(a) amplifying at least two nucleotide sequences from a single nucleic acid molecule template using primer pairs to produce double-stranded amplified products, wherein the amplified nucleotide sequences reside noncontiguously in the nucleic acid molecule template, wherein each primer of a primer pair comprises an uninterrupted recognition sequence for a class IIS restriction endonucicase which is located near the 5′-end of the primer and a portion of an amino acid coding sequence, such that cleavage of the amplified products with the class IIS restriction endonuclease yields at least two nucleic acid molecule fragments with cohesive ends that, when ligated to each other, produce a continuous nucleotide sequence capable of being transcribed and translated to produce a protein of interest,
(b) cleaving amplified products with the class IIS restriction endonuclease to produce nucleic acid molecule fragments, and
(c) ligating cleaved nucleic acid molecule fragments to produce a nucleic acid molecule comprising the continuous nucleotide sequence capable of being transcribed and translated to produce a protein of interest.

### Claim 2

A method for producing a nucleic acid molecule that comprises a continuous nucleofide sequence capable of being transcribed and translated to produce a protein of interest, the nucleic acid molecule derived from nonconziguous nucleolide sequences, comprising:
(a) amplifying at least two nucleotide sequences from at least two nucleic acid molecule templates using primer pairs to produce double-stranded amplified products, wherein at least one primer of a primer pair comprises an uninterrupted recognition sequence for a class IIS restriction endonuclease which is located near the 5′-end of the primer and a portion of an amino acid coding sequence, such that cleavage of the amplified products with the class IIS restriction endonuclease yields at least two nucleic acid molecule fragments with cohesive ends that, when ligated to each other, produce a continuous nucleotide sequence capable of being transcribed and translated to produce a protein of interest,
(b) cleaving amplified products with the class IIS restriction endonuclease to produce nucleic acid molecule fragments, and
(c) ligating cleaved nucleic acid molecule fragments to produce a nucleic acid molecule comprising the continuous nucleotide sequence capable of being transcribed and translatcd to produce a protein of interest.

### Claim 3 (depends on 1)

The method of claim 1, wherein the class IIS restriction endonuclease recognizes a five-base uninterrupted recognition sequence.

### Claim 4 (depends on 3)

The method of claim 3, wherein the class IIS restriction endonuclease is selected from the group consisting of AclWI, Alw26I, AlwI, AsuHPI, BbvI, BcefI, BinI, BseGI, BseMII, BseXI, BspPl, BsmAI, Bst7II, BstF5I, FauI, FokI, HgaI, HphI, MboI, PleII, SfaNI, and TspRI.

### Claim 5 (depends on 1)

The method of claim 1, wherein the class IIS restriction endonuclease recognizes a six-base uninterruptcd recognition sequence.

### Claim 6 (depends on 5)

The method of claim 5 wherein the class IIS restriction endonuclesse is selected from the group consisting of AceIII, BbsI, BbvII, Bce83I, BciVI, BfiI, BfuI, BmrI, BpiI, BpmI, BpuAI, BsaI, Bse3DI, BseRI, BsgI, BsmBI, BsmFI, BspMI, BsrDI, Bsu6I, EamlI104I, EarI, Eco31I, Eco57I, Esp3I, FauI, GsuI, Ksp632I, MmeI, RleAI, TaqII, and Tthl111II.

### Claim 7 (depends on 1)

The method of claim 1, wherein the class IIS restriction endonuclease recognizes a seven-base uninterrupted recognition sequence.

### Claim 8 (depends on 7)

The method of claim 7, wherein the class IIS restriction endonuclease is SapI.

### Claim 9 (depends on 1)

The method of claim 1, wherein the nucleic acid molecule template is selected from the group consisting of genomic DNA, cDNA, vector DNA, and a chemically-synthesized nucleic acid molecule.

### Claim 10 (depends on 2)

The method of claim 2, wherein at least one nucleic acid molecule template is selected from the group consisting of genomic DNA, cDNA, vector DNA, and a chemically-synthesized nucilic acid molecule.

### Claim 11 (depends on 1)

The method of claim 1, wherein each of the amplified products comprises at least a portion of an exon.

### Claim 12 (depends on 1)

The method of claim 1, wherein at least one of the amplified products comprises at least a portion of an exon, and at least one of the amplified products comprises a nucleotidc sequence capable of controlling gene expression.

### Claim 13 (depends on 1)

The method of claim 1, wherein each of the amplified products comprises an exon.

### Claim 14 (depends on 13)

The method of claim 13, wherein one primer of each primer pair is partially complementary to the antisense strand of the 5′ end of an exon, and wherein the other primer of each primer pair is partially complementary to the sense strand of the 3′-end of the exon.

### Claim 15 (depends on 1)

The method of claim 1 wherein at least one of the amplified products comprises at least one mutation of the nucleotide sequence, which resides in the corresponding nucleic acid molecule template.

### Claim 16 (depends on 18)

The method of claim 18, wherein at least one mutation resides in an amino acid encoding sequence.

### Claim 17 (depends on 1)

The method of claim 1, wherein the act of amplification is performed using a polymerase chain reaction.
